Last $8.17 USD
Change Today +0.18 / 2.25%
Volume 436.1K
PACB On Other Exchanges
Symbol
Exchange
Frankfurt
As of 4:00 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

pacific biosciences of calif (PACB) Key Developments

Pacific Biosciences of California, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 10:00 AM

Pacific Biosciences of California, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 10:00 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Michael W. Hunkapiller, Executive Chairman, Chief Executive Officer, President and Member of Compensation Committee.

Pacific Biosciences of California, Inc. Appoints Kathy Ordoñez to the Board of Directors

Pacific Biosciences of California, Inc. announced that it has appointed Kathy Ordoñez to its Board of Directors. Ordoñez has a 30 year history of leadership in the life sciences and diagnostics industries, including positions as Senior Vice President of Quest Diagnostics, Chief Executive Officer of Celera, founder of Celera Diagnostics, and President and Chief Executive Officer for Roche Molecular Systems.

Pacific Biosciences of California, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014

Pacific Biosciences of California, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 . Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States.

Pacific Biosciences Mulls Acquisitions

Pacific Biosciences of California, Inc. (NasdaqGS:PACB) intends to pursue acquisitions. Pacific Biosciences has filed a Shelf Registration to raise $150 million. The company plans to use the net proceeds for general corporate purposes, which may include working capital, capital expenditures, other corporate expenses and acquisitions of complementary products, technologies or businesses.

Suqian Lakeside Pangu Gene Company to Use PacBio Single Molecule, Real-Time (SMRT(R)) Sequencing

Pacific Biosciences of California, Inc. and Suqian Lakeside Pangu Gene Company announced that SLPC has established a new genomics facility with 1,500 square meters of laboratory space in the Tianjin Dong Li Lake Technology Park, dedicated to using PacBio Single Molecule, Real-Time (SMRT(R)) Sequencing as the major sequencing platform for its translational medicine research projects. SLPC purchased four PacBio RS II Sequencing Systems earlier this year and recently installed them at their newly dedicated facility. The company ultimately intends to focus on applications such as molecular-based approaches for early diagnosis of cancers, disease recurrence control and drug efficacy evaluation.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PACB:US $8.17 USD +0.18

PACB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Enzo Biochem Inc $3.13 USD -0.12
Fluidigm Corp $39.78 USD +2.07
Luminex Corp $17.90 USD +0.15
NanoString Technologies Inc $13.38 USD +0.86
Sequenom Inc $3.68 USD +0.09
View Industry Companies
 

Industry Analysis

PACB

Industry Average

Valuation PACB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.7x
Price/Book 10.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIFIC BIOSCIENCES OF CALIF, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.